The Antibody Society

the official website of the antibody society

The Adaptive Immune Receptor Repertoire Community of The Antibody Society

  • LOG IN
  • BECOME A MEMBER
  • About Us
    • Our Team
      • Directors and Officers
      • Our Staff
      • Our Committees
    • Sponsors & Partners
  • Events Calendar
    • Current Events
  • AIRR Community
    • AIRR Community News
    • AIRR Community Newsletter
    • AIRR Community Seminar Series
    • AIRR Community Meetings
      • Zooming into the Community III
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • On AIRR – An AIRR Community Podcast
    • AIRR Data Commons
    • AIRR-C Germline Database Resources
    • AIRR Community Publications
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-Committees
      • Communications Sub-Committee
      • Executive Sub-Committee
      • Inferred Allele Review Committee
      • Meetings Sub-Committee
      • Strategic Planning Sub-Committee
    • AIRR Community Webinar Series
    • AIRR Community Calendar
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2025 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2025 James S. Huston Antibody Science Talent Award Recipient
      • 2024 James S. Huston Antibody Science Talent Award Recipient
      • 2023 James S. Huston Antibody Science Talent Award Recipient
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award submission guidelines
    • Research Competitions
      • The Antibody Society’s Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2025 Calendar
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings in 2025
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody News Podcast
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars in 2025
    • The Antibody Series Lectures 2025
    • Antibody Discovery & Development
    • Adaptive Immune Receptor Repertoires
    • Antibodies to Watch
    • Commercializing Antibody Therapeutics
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
You are here: Home / The AIRR Community / AIRR Community Working Groups / Software Working Group

Software Working Group

This Working Group has been disbanded as of 2024. The Software Working Group will remain formally active as a working group only through submission and ratification of a manuscript. No additional regular WG meetings are planned. Maintenance of the software standards and certification of tools as compliant with them will be passed to the new ML/AI WG. Many of our current members are planning to join that new WG, as well.

Achievements

We have defined a standard for AIRR-Seq software tools. We will promote this over the next year, as a way of encouraging inter-operation and adoption of AIRR standard protocols by providing community support and publicity to compliant tools. We have also started work (in collaboration with the Germline Database Working Group) on an initiative to assess the biological credibility of an AIRR-Seq repertoire, and to identify common technical errors that can occur during its preparation, which can be heard to spot from read quality annotations and other technical measures commonly available today.

Goals

To make it easy to do rigorous analysis of AIRR-seq data.

For 2022-2024:

  • Completion of RepCred
  • Alignment of benchmarking and gold-standards dataset with PrecisionFDA activities
  • Surveying our AIRR-C membership for key focus areas (particular emphasis on industry needs)
  • Supporting the Communications SC industry initiative by drawing on members’ knowledge of the tools marketplace

Long-term vision and how WG products integrate with the AIRR-C mission:

The purpose of our working group is to encourage practices that enable software tools to work, and to work with one another: this dovetails with the AIRR-C mission to improve methods and standards. We aim to promote awareness of AIRR standards within the software tools community, and to provide a forum through which software tools developers can discuss and progress topics of mutual interest.

Resources

  • Compliance Checklist for AIRR Software Tools
  • AIRR Software WG – List of Tools Certified as Compliant
  • Gold standard datasets

Members

Co-Leaders: William Lees and Chaim Schramm

Members: Bryan Briney, Brian Corrie, Noah Yann Lee, Georgina Leslie, William Lees (Co-lead) Susanna Marquez, Luke Myers, Mats Ohlin, Chaim Schramm (Co-lead), Adrian Shepherd, and Wenming Xiao.

Contact Us

software@airr-community.org
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners Old
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals